Poor Timing | Chemical & Engineering News
Volume 85 Issue 39 | p. 6 | Letters
Issue Date: September 24, 2007

Poor Timing

Department: Letters

AstraZeneca transferring production to China is a very poor move (C&EN, July 30, page 40). At a time when products coming from China are highly suspect for major quality defects, and when critical products such as pharmaceuticals are not being labeled with country of origin, most of us will be reluctant to trust AstraZeneca's pharmaceuticals. My family and I will avail ourselves of other companies' products whenever possible.

Peter R. Lantos
Erdenheim, Pa.

 
Chemical & Engineering News
ISSN 0009-2347
Copyright © American Chemical Society

Leave A Comment

*Required to comment